Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
about
Unique molecular characteristics of pediatric myxopapillary ependymomaNew chemotherapy strategies and biological agents in the treatment of childhood ependymomaBiological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspectiveMicroarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3Spinal cord tumours: advances in genetics and their implications for treatmentClassification of cancer cell lines using an automated two-dimensional liquid mapping method with hierarchical clustering techniques.A prognostic gene expression signature in infratentorial ependymoma.Genomic characterization of ependymomas reveals 6q loss as the most common aberrationA clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo.Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients.Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression.Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients.Classification and controversies in pathology of ependymomas.Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adult.Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network.Comparative genomic hybridization in central and peripheral nervous system tumors of childhood and adolescence.Infratentorial ependymomas--a study of the centre in KatowiceIsoSeq analysis and functional annotation of the infratentorial ependymoma tumor tissue on PacBio RSII platform.OMICS and brain tumour biomarkers.Biology and management of ependymomas.Selective Raf inhibition in cancer therapy.Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients.Molecular neuropathology of gliomas.Surgical management of supratentorial ependymomas.Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients.Involvement of the IGF system in fetal growth and childhood cancer: an overview of potential mechanisms.Ependymomas in adults.Tumor profiling: development of prognostic and predictive factors to guide brain tumor treatment.Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomasSpinal cord ependymomas in children and adolescents.Ependymoma in children: molecular considerations and therapeutic insights.Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.Posterior fossa ependymoma: current insights.Pediatric Ependymoma.Understanding Ependymoma Oncogenesis: an Update on Recent Molecular Advances and Current Perspectives.Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro.Evaluation of chromosome 1q gain in intracranial ependymomas.Expression alterations define unique molecular characteristics of spinal ependymomasDecreased expression of antioxidant enzymes is associated with aggressive features in ependymomas.
P2860
Q24616458-DCA79B54-D832-475A-9AF7-8891B2562A82Q24658324-48217C30-AD64-4A41-8B74-A180FA837384Q24658389-3DD15107-ADD7-4A04-93EA-6FB76E4BA466Q24683906-4DBEF107-D5D6-4F93-9CD9-BA01E1FA66BEQ26851596-5A9226A4-6500-4E12-9837-C3729166119CQ33222790-81AF6A9B-4D8E-4FDA-9DEE-5F0D205F4218Q33581494-6B9B7403-D63B-4B0A-8FEA-A30C245EEBC8Q33881660-DD685F6B-077E-47E3-853C-7A0362287C18Q34132933-C780F51A-8B86-4F1E-8132-F3588038B966Q34133129-FD3B004A-2A1C-4B33-B42A-B1311D228C9CQ34367176-A401ACB3-BC53-4965-B465-0F5D6675AB20Q34778529-EF5F4E70-BA5D-4BA3-B942-E98E2C581C3EQ34943656-279674EE-8F6E-4CF2-A1D6-E928296C51A8Q35678373-825F4905-7122-4013-B94A-366BF517CF4FQ35788836-20CC0C6B-45A4-453D-A8DA-D8B8886098B3Q35805725-F3C88010-46F3-4F93-B988-3E62C870DE89Q35825515-285BF2B6-F65B-418B-9272-3E102463DE62Q35919275-2081BA2C-635D-4DA2-ABE1-507D2781AD50Q36665688-5A0D3E37-84D3-4634-83E4-4070B066079EQ36977704-BC745165-8FB5-4991-BC77-A7ED980D4D78Q37004743-334040DB-6E57-4AF9-92CE-BDEA1E88A62DQ37159440-F6F40A61-FDA0-4B0B-B2C9-3C0F82858906Q37427424-3FECDD7E-4871-4DED-8D1A-5BC298EC3EE7Q37439392-3054F6E4-3C97-4057-B070-FE05FB6CA42FQ37508720-F0F786BA-CD32-4376-8507-AEA1809C8996Q37522065-CF2911C5-A9C0-4C67-8194-4B7E51B23E63Q37738142-D3E834E1-A9F1-4AAD-B434-E73BAFA2AA9DQ37809998-716F701B-1908-4191-AF33-B9803FD2FF95Q38003799-656D8669-0A4B-4EBF-9D2F-1A364C2C1E16Q38041984-018D2288-904F-4CBE-8F29-6ABB0E5224D5Q38101501-B24FF781-945E-4874-A393-26F7F5BC2913Q38443010-E5B0E7C5-97EC-4627-A734-7831AD75D2C2Q38509851-CAC5EB26-2546-4AB0-A5AF-4D18A1A8DF04Q38583252-69BE5666-74FF-4C03-94A5-306BBB7FE158Q38616800-932042D9-4829-4A09-AFFB-BC1FF85921CBQ38681915-E355D2DD-AED1-4DE3-888E-99D91D98C248Q39430360-0F43A528-D8D2-45C4-B93F-A7ACD8825364Q40150706-4685E3AB-5A71-4B07-B9B9-36ED3A805F20Q41018921-CD3AD13C-896B-4C2C-A8AA-2624A9D97522Q43579111-43F8C899-46A2-4AB1-9520-C4EB318DB562
P2860
Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Gene expression patterns in ep ...... ation, grade, and patient age.
@en
Gene expression patterns in ep ...... ation, grade, and patient age.
@nl
type
label
Gene expression patterns in ep ...... ation, grade, and patient age.
@en
Gene expression patterns in ep ...... ation, grade, and patient age.
@nl
prefLabel
Gene expression patterns in ep ...... ation, grade, and patient age.
@en
Gene expression patterns in ep ...... ation, grade, and patient age.
@nl
P2093
P2860
P1476
Gene expression patterns in ep ...... ation, grade, and patient age.
@en
P2093
Andrey Golanov
Andrey Korshunov
Axel Benner
Bjoern Tews
Gunnar Wrobel
Meinhard Hahn
P2860
P304
P356
10.1016/S0002-9440(10)63530-4
P407
P577
2003-11-01T00:00:00Z